NCT06161974 2025-02-21Study of Olutasidenib and Temozolomide in HGGRigel PharmaceuticalsPhase 2 Recruiting60 enrolled
NCT03684811 2023-11-18A Study of FT-2102 in Patients With Advanced Solid Tumors and Gliomas With an IDH1 MutationNovo Nordisk A/SPhase 1/2 Completed93 enrolled 24 charts